These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2676935)

  • 1. Mutants of the TEM-1 beta-lactamase conferring resistance to ceftazidime.
    Payne DJ; Marriott MS; Amyes SG
    J Antimicrob Chemother; 1989 Aug; 24(2):103-10. PubMed ID: 2676935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime.
    Payne DJ; Marriott MS; Amyes SG
    FEMS Microbiol Lett; 1989 May; 50(1-2):97-100. PubMed ID: 2661324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences.
    Rasmussen BA; Bradford PA; Quinn JP; Wiener J; Weinstein RA; Bush K
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1989-92. PubMed ID: 8239618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri.
    Yang Y; Bhachech N; Bradford PA; Jett BD; Sahm DF; Bush K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1671-6. PubMed ID: 9661002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy.
    Jacquier H; Marcadé G; Raffoux E; Dombret H; Woerther PL; Donay JL; Arlet G; Cambau E
    J Antimicrob Chemother; 2013 Dec; 68(12):2792-6. PubMed ID: 23861309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo selection of a chromosomally encoded beta-lactamase variant conferring ceftazidime resistance in Klebsiella oxytoca.
    Mammeri H; Poirel L; Nordmann P
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3739-42. PubMed ID: 14638475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
    Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.
    Vuye A; Verschraegen G; Claeys G
    Antimicrob Agents Chemother; 1989 May; 33(5):757-61. PubMed ID: 2665644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins.
    Bauernfeind A; Hörl G
    Infection; 1987; 15(4):257-9. PubMed ID: 3312022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A novel extended-spectrum beta-lactamase in a ceftazidime-resistant isolate of E. coli].
    Cheng Y; Li Y; Chen M
    Wei Sheng Wu Xue Bao; 1994 Oct; 34(5):360-6. PubMed ID: 7871780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
    Thomson CJ; Amyes SG
    J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates.
    Pörnull KJ; Göransson E; Rytting AS; Dornbusch K
    J Antimicrob Chemother; 1993 Oct; 32(4):559-70. PubMed ID: 8288497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli.
    Weber DA; Sanders CC; Bakken JS; Quinn JP
    J Infect Dis; 1990 Aug; 162(2):460-5. PubMed ID: 2197339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
    Chouchani C; Ben-Achour N; M'charek A; Belhadj O
    C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.
    Sirot D; Recule C; Chaibi EB; Bret L; Croize J; Chanal-Claris C; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1322-5. PubMed ID: 9174192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
    Chanal-Claris C; Sirot D; Bret L; Chatron P; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Mar; 41(3):715-6. PubMed ID: 9056022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of extended-spectrum activity in TEM beta-lactamases in hyper-mutable, mutS Escherichia coli.
    Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
    Clin Microbiol Infect; 2006 Aug; 12(8):800-3. PubMed ID: 16842578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent evolution of TEM-26, a beta-lactamase with extended-spectrum activity.
    Hibbert-Rogers LC; Heritage J; Todd N; Hawkey PM
    J Antimicrob Chemother; 1994 Apr; 33(4):707-20. PubMed ID: 8056689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.